FC
MRK icon

Farringdon Capital’s Merck MRK Stock Holding History

Farringdon Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,120
Closed -$1.1M – 340
2026
Q1 		$1.1M Sell
9,120
-12,927
-59% -$1.49M 0.24% 125
2025
Q4 		$2.32M Buy
+22,047
New +$2.07M 0.57% 41
2025
Q2 		– Sell
-2,364
Closed -$212K – 535
2025
Q1 		$212K Buy
+2,364
New +$221K 0.11% 279

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Farringdon Capital's MRK Position: Q2 2026 in Review

Farringdon Capital sold out of Merck (MRK) in Q2 2026, closing a stake of 9,120 shares — an estimated $1.1M sold.

Farringdon Capital first reported a position in MRK in Q1 2025 and held it in 3 quarters. The position peaked at $2.32M in Q4 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Farringdon Capital reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Farringdon Capital sold 9,120 Merck shares in Q2 2026, an estimated $1.1M.
  • Farringdon Capital first reported a position in Merck in Q1 2025 and held it in 3 quarters.
  • Farringdon Capital's Merck position peaked at $2.32M in Q4 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.